Multiomics platform enabling 2-day QC release and characterization of cell therapy products

Authors

• Dwight Baker, Cellanome, Inc., USAFollow
• Shawn Levy, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Tierney Bougie, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Sophia Espanola, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Laura Smith, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Isabella Vahrson, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Fan Yang, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Ekta Dadlani, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Saege Hancock, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Dave Robbins, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Brandon Razooky, Neeraj Salathia, Cellanome, Inc., Foster City, CA
• Anne Decker, Neeraj Salathia, Cellanome, Inc., Foster City, CA

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Dwight Baker, Shawn Levy, Tierney Bougie, Sophia Espanola, Laura Smith, Isabella Vahrson, Fan Yang, Ekta Dadlani, Saege Hancock, Dave Robbins, Brandon Razooky, and Anne Decker, "Multiomics platform enabling 2-day QC release and characterization of cell therapy products" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/42